Does Kaiser Permanente Cover Vyvanse?
The verdict
Covered on most plans
Kaiser Permanente covers Vyvanse on its closed, integrated formulary, dispensed through Kaiser pharmacies — generic lisdexamfetamine is the preferred option, brand Vyvanse routes through Kaiser's internal formulary-exception process. A Schedule II 70 mg/day quantity limit and documented ADHD diagnosis are required. Because Kaiser is a closed HMO, the generic-lisdexamfetamine supply transition and any shortage substitution are managed internally rather than via an external PBM — members cannot take prescriptions to an outside pharmacy.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Kaiser Permanente using your member ID.
Key facts
Kaiser is a closed integrated HMO — all Vyvanse/lisdexamfetamine fills must go through Kaiser pharmacies; no outside-pharmacy option exists during shortages.
Kaiser Permanente member plan documentation
The DEA set the 2026 lisdexamfetamine APQ at 51,290,743 grams (January 5, 2026), up from 39.9 million grams in 2025, to address supply shortfalls.
DEA Final Order, effective January 5, 2026
Generic lisdexamfetamine (approved August 2023) is Kaiser's formulary-preferred option; brand Vyvanse requires an internal formulary exception.
FDA ANDA records; Kaiser regional formulary documentation
Medicare vs. commercial coverage
Whether Kaiser Permanente covers Vyvanse depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Under Kaiser Senior Advantage (Medicare Advantage/Part D), generic lisdexamfetamine is covered and preferred; brand Vyvanse may require an internal exception or prior authorization. A Schedule II 70 mg/day quantity limit applies. Medicare beneficiaries cannot use manufacturer savings cards. Verify on your Kaiser Senior Advantage formulary for your region.
Commercial / Employer
Group & marketplace plans
On Kaiser HMO Commercial/Employer and ACA/Individual (marketplace) plans, generic lisdexamfetamine is covered on the closed formulary at a low HMO cost-share; brand Vyvanse requires an internal formulary exception. On Medicaid plans where Kaiser operates (e.g., California, Oregon), generic lisdexamfetamine is covered per state PDL and Kaiser formulary with PA and QL requirements; nominal Medicaid cost-share applies. The key structural point: all fills go through Kaiser pharmacies — there is no outside-pharmacy option if Kaiser's internal supply is short during the ongoing shortage.
The 4 boxes you must tick to get approved
Commercial plans that will consider Vyvanse require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 4 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Vyvanse actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Generic lisdexamfetamine: ~$200–$360 per month cash (as low as ~$60–$70 with coupon). Brand Vyvanse: ~$400–$558 per month. Estimates only — varies by pharmacy and dose.
List price with no coverage — before any manufacturer savings card.
With coverage
Generic: low HMO cost-share at Kaiser pharmacies (plan-specific; verify on Kaiser regional benefit summary). Brand Vyvanse: higher cost-share if internal exception granted. Kaiser Senior Advantage (Medicare): tier/phase-dependent; Medicare members cannot use manufacturer coupons. Verify on your Kaiser regional plan.
Typical monthly copay once prior authorization is approved.
All dollar figures are estimates and vary by Kaiser regional plan and dose. Verify on your Kaiser membership materials or Kaiser regional formulary. Medicare Senior Advantage members cannot use manufacturer coupons.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Check the Kaiser formulary for your region
Log in to kp.org and use the drug search tool to look up 'lisdexamfetamine' or 'Vyvanse' on your regional Kaiser formulary. Kaiser operates separate regional formularies — the specific tier, quantity limit, and exception process vary by region (California, Colorado, Georgia, Hawaii, Mid-Atlantic, Northwest, Washington).
- 2
Talk to your Kaiser physician
Unlike external-PBM insurers, Kaiser manages formulary exceptions internally — your Kaiser physician initiates a formulary exception request for brand Vyvanse if medically necessary. Contact your Kaiser primary care physician or psychiatrist to discuss your specific coverage and whether a generic-to-brand exception is appropriate.
- 3
Call Kaiser Member Services or check stock at your Kaiser pharmacy
Call the member services number on your Kaiser card or contact your local Kaiser pharmacy directly to verify generic lisdexamfetamine stock. Because fills go through Kaiser pharmacies only, knowing your Kaiser location's current stock level is essential — especially given the ongoing stimulant shortage. Your Kaiser physician manages substitution to brand if the generic is unavailable internally.
Options if Kaiser Permanente won't cover Vyvanse
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Generic lisdexamfetamine
The Kaiser-preferred option on the closed formulary. FDA-approved August 2023 — therapeutically equivalent to brand Vyvanse, dispensed through Kaiser pharmacies.
Generic amphetamine/dextroamphetamine (Adderall generic)
FDA-approved for ADHD; generally on Kaiser's closed formulary at a low tier with a ~60 mg/day QL. An internal alternative when lisdexamfetamine supply is constrained.
Generic methylphenidate (Ritalin)
Non-amphetamine Schedule II ADHD stimulant on Kaiser's formulary. An option when amphetamine-class supply is limited through Kaiser pharmacies.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Kaiser is a closed integrated HMO — all formulary prescriptions, including Vyvanse and generic lisdexamfetamine, must be filled at Kaiser pharmacies. There is no option to take the prescription to an outside pharmacy. This means that if your Kaiser pharmacy is temporarily out of generic lisdexamfetamine due to the ongoing shortage, your Kaiser physician manages the substitution internally (either finding the generic at another Kaiser location or initiating a brand-Vyvanse exception within the system) rather than sending you to an external pharmacy.
Kaiser's closed formulary prefers generic lisdexamfetamine — brand Vyvanse is non-preferred and requires an internal formulary exception. Unlike external-PBM insurers where you file a PA through a PBM portal, at Kaiser your prescribing physician initiates the exception request within the Kaiser integrated system. During the stimulant shortage in 2024, some Kaiser regions temporarily accommodated brand Vyvanse when generic supply was thin; as generic supply improves following the DEA's 2026 quota increase to 51.3 million grams, generic lisdexamfetamine is the standard formulary preference.
Kaiser applies a Schedule II quantity limit for lisdexamfetamine consistent with the industry standard of 70 mg per day. Kaiser operates regional formularies, so the exact quantity limit may vary by Kaiser region. Your Kaiser physician can confirm the QL for your region, and the Kaiser drug formulary search on kp.org provides plan-specific details. Do not assume that FEP or OptumRx criteria apply directly — verify on your specific Kaiser regional formulary.
The generic-lisdexamfetamine-preferred outcome is the same across Kaiser and external-PBM insurers like UHC (OptumRx), Anthem (CarelonRx), or Aetna (CVS Caremark). The structural difference is that Kaiser manages everything internally — formulary exceptions, shortage substitutions, and pharmacy dispensing all happen through the Kaiser system. External-PBM insurers send you to any in-network pharmacy with a documented PA or pharmacist override; Kaiser keeps the entire process inside its integrated network, which means no outside-pharmacy fallback but also potentially faster internal resolution.
Related Articles
Does Kaiser Permanente Cover Eliquis? Coverage & Cost 2026
Yes — Kaiser covers Eliquis for AFib and VTE on its closed-network formulary. Must fill at Kaiser pharmacy. 2026 IRA price $231 for Senior Advantage.
Read moreDoes Kaiser Permanente Cover Qsymia? 2026 | Curex
Kaiser's closed HMO limits Qsymia access; Medi-Cal excluded weight-loss drugs in 2026. Engage cash program ~$89/mo; generic launched 2025.
Read moreDoes Kaiser Permanente Cover Cialis? 2026 | Curex
Kaiser Permanente does not cover Cialis for ED — Medicare Part D bars it by law and commercial plans exclude it. Generic tadalafil IS covered for BPH.
Read moreDoes Kaiser Permanente Cover Jardiance? 2026
Kaiser Permanente covers Jardiance on its closed-network formulary for T2D. Metformin-first step may apply. 2026 MFP $197; $2,100 cap for Medicare.
Read moreDoes Kaiser Permanente Cover Ozempic? 2026 Guide | Curex
Kaiser NW covers Ozempic for T2D — requires metformin plus SGLT-2 step therapy, strictest in the cluster. Tier 3, closed network, weight-loss excluded.
Read moreDoes Kaiser Permanente Cover Viagra? 2026 Guide
Kaiser Permanente does not cover Viagra for ED. The Medicare Part D statutory exclusion applies. Only covered path: sildenafil (Revatio) for PAH.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Kaiser Permanente before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.